A Legionella-like organism (strain 82A3105; ATCC 43736) was isolated from a lung aspirate taken from a patient with pneumonia. Results of physiologic, gas-liquid chromatographic, genetic, and serologic tests showed that strain 82A3105 and four additional clinical isolates belong to a new Legionella pneumophila serogroup, serogroup 13.
Twelve serogroups of Legionella pneumophila, all of which can cause human pneumonia, have been described (2, (4) (5) (6) The five Legionella-like strains were tested for catalase, oxidase, gelatinase, and urease activities as described previously (7), except that 1% N,N-dimethyl-p-phenylenediamine oxalate was substituted for tetramethyl-p-phenylenediamine dihydrochloride in the oxidase test. The ability to reduce nitrate was tested with BCYE broth supplemented with 0.1% KNO3. ,B-Lactamase testing was done with Cefinase disks (BBL Microbiology Systems). Hippurate hydrolysis was determined by the method of Hébert (1) . Colonies were examined for autofluorescence with a Wood's lamp (8) . The isolates were tested for their ability to grow on BCYE agar, BCYE agar without cysteine, and sheep blood agar (8) . Cellular fatty acids were analyzed by capillary-column gasliquid chromatography (3). Previously described methods were used for the slide agglutination test (5) and DNA relatedness studies (9) .
All five strains were gram-negative rods that grew on BCYE agar but not on BCYE agar without cysteine or on sheep blood agar. Ail were positive for catalase, gelatinase, hippurate hydrolysis, and ,B-lactamase and negative for urease, nitrate reduction, and autofluorescence. The oxidase reaction varied from negative to weakly positive among the five strains. Their cellular fatty acid profiles were consistent with the pattern described for L. pneumophila (3) . DNAs from the five strains were 98% or more related to labeled DNA from Seattle 1. The relatedness of Seattle 1 to L. pneumophila Philadelphia 1 (type strain) was 75% or higher at both optimal (60°C) and stringent (75°C) criteria for DNA reassociation, and related sequences contained only 1.5% unpaired bases (divergence). These data confirm the identity of the strains as L. pneumophila.
In the slide agglutination test, Seattle 1 antiserum at its use dilution (1:32) agglutinated all five strains 4+. Cross-reactions with strains Los Angeles 1 (serogroup 4) and Leiden 1 (serogroup 10) and two Legionella-like organisms, 1335JD and 1347JD, were removed by absorbing Seattle 1 antiserum with strain Leiden 1 without affecting the homologous reaction. When Seattle 1 and the 4 Seattle 1-reactive California isolates were tested with unabsorbed antisera to all known Legionella species and serogroups, they agglutinated only with 1335JD and Leiden 1 antisera. The cross-reactions were removed by absorbing the antisera with strain Seattle 1. These results show that the four California strains and Seattle 1 belong to a new serogroup of L. pneumophila, serogroup 13. The reference strain for this serogroup is 82A3105 (CDC 1425-CA-H; ATCC 43736).
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